Skin Bioprinting Articles & Analysis
3 news found
As one of the first results of the collaboration initiated in early 2020 between the Cell Culture and Therapy Laboratory (« LCTC ») of the AP-HM and the Poietis company, this installation is a major milestone in the roadmap to start the first clinical trial of a 3D bioprinted human tissue, which will be a skin substitute bioprinted ...
ByPoietis
The SAB will serve as a key strategic resource to Poietis as the company expands capabilities of Next- Generation Bioprinting (NGB) platform to therapeutic applications and develops first implantable tissues such as a bioprinted skin substitute in collaboration with the Assistance Publique – Hôpitaux de Marseille. ...
ByPoietis
Poietis has developed the multimodal NGB (« Next Generation Bioprinting ») bioprinting platform declined in two versions: one for in vitro tissue engineering research (NGB-R) and a clinical version (NGB-C) for the production of implantable bioprinted tissues. ...
ByPoietis